drugset / Trial / NCT02558088
Pharmacological Properties of Salmeterol
NaSingle-groupOpen-labelBasic science
Summary
The objective of the study is to help establish a urinary threshold for salmeterol on the World Anti-doping Agency prohibited list, to avoid supratherapeutic of this substance in competitive sports. Hence, there is no hypothesis as such.
Timeline
- Start
- 2014-09
- Primary completion
- 2016-07
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Salmeterol | Other / unclassified | — | — |
Indications
No indication recorded.